Tag: UPCH

Pedro E. Romero: “Science is not about opinions, but about evidence” |  INTERVIEW
News

Pedro E. Romero: “Science is not about opinions, but about evidence” | INTERVIEW

According to the criteria ofKnow moreAt El Comercio we continue with our series of interviews with relevant people from the peruvian science. The excerpt presented below is part of the new podcast series “Peruvian Minds”, Where we will seek to know what is behind Peruvian scientists, researchers and experts.READ ALSO: Enrique Gil: "In quarantine we had to improve our weaknesses"He never thought that his studies on the genetic diversity in fan shells would lead him to be part of a team of experts that tirelessly seeks to identify new variants of SARS-CoV-2. Trade spoke with Pedro Romero, doctor in Natural Sciences, about the usefulness of basic sciences in a global emergency such as pandemic we are going through.- What has been done right and wrong after a year of pandemic in Peru?The go...
Vaccination against COVID-19 of Sinopharm clinical trial volunteers will begin this Monday, May 24
News

Vaccination against COVID-19 of Sinopharm clinical trial volunteers will begin this Monday, May 24

Sergio Recuenco, principal investigator of the clinical trial of the vaccine against coronavirus (COVID-19) from the laboratory of Sinopharm, announced that the vaccination process for volunteers will begin on May 24.SIGHT: COVID-19 vaccine: more than one million 761 thousand have already been immunized against the coronavirusIn dialogue with RPP, the specialist explained that the 16,500 doses arrived last Saturday and that they are in the process of removing them from warehouses. He emphasized that this Monday the lifting of the blind began, which contains information regarding whether a participant received a placebo or a vaccine.SIGHT: COVID-19: people over 65 will be vaccinated from this weekendHe affirmed that the volunteers who received placebo and the Wuhan strain vaccine, which in...
Sinopharm vaccine: Digemid authorizes import of doses to apply to volunteers in clinical trials
News

Sinopharm vaccine: Digemid authorizes import of doses to apply to volunteers in clinical trials

The General Directorate of Medicines, Supplies and Drugs, an entity of the Ministry of Health (Minsa), announced this Wednesday that it authorized the import of a batch of 16,500 doses of the vaccine against COVID-19 from Sinopharm to apply them to the volunteers who participated in the clinical trials developed by the Universidad Peruana Cayetano Heredia (UPCH)“Yesterday, the request was received from the Cayetano Heredia University for the import authorization of 16,500 doses of the Sinopharm Beijing vaccine, and just a few moments ago we were notifying the directorial resolution No. 4595-2021, for which the import is being authorized for research purposes”Carmen Ponce, director of Digemid, told RPP Televisión.SIGHT: Vaccination of adults over 80 years of age: this Friday, May 7, the a...
UPCH reported that the doses of Sinopharm to vaccinate clinical trial volunteers will arrive in Peru the fourth week of May
News

UPCH reported that the doses of Sinopharm to vaccinate clinical trial volunteers will arrive in Peru the fourth week of May

Following the warning made by the participants in the clinical trial of the vaccine against COVID-19 from the laboratory Sinopharm, to initiate legal actions because they have not yet been immunized, the Peruvian University Cayetano Heredia (UPCH) reported -this Thursday- that a batch of doses would arrive in the fourth week of May to be applied to the volunteers.SIGHT: The Ministry of Health reported that this Friday 27,629 people over 70 were vaccinated in Lima“The logistical coordination for export and transport to Peru will last approximately two weeks, anticipating that the vaccine will arrive in Peru during the fourth week of May”, Indicated the UPCH in a statement.SIGHT: Minister Ugarte on the second wave of COVID-19: "We are on the cusp, let's hope it starts to decrease"In additi...
COVID-19 |  Researchers complete development of rapid saliva molecular test
News

COVID-19 | Researchers complete development of rapid saliva molecular test

According to the criteria ofKnow moreFrom the Research and Development Laboratories of the Cayetano Heredia Peruvian University, researchers from that study house, with the collaboration of experts from Essalud, the Stanford (USA) and Kiel (Germany) universities and the Riken Institute (Japan). ), announced the culmination of the development of a rapid molecular test, which uses saliva to detect SARS-CoV-2 in as little as 40 minutes.LEE: Hospital Hipólito Unanue started using rapid COVID-19 molecular tests manufactured in PeruThrough your Twitter account, Dr. Edward Málaga-Trillo, leader of the investigation, made the public announcement.1/32. I share the results of the field study of our rapid molecular saliva testGo to the statement, link to the article sent today for pre-publication and...